News from kempharm, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 10, 2015, 08:10 ET KemPharm, Inc. Appoints David S. Tierney, MD to Board of Directors

KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity...


Mar 04, 2015, 08:10 ET KemPharm, Inc. Appoints Tracy M. Woody as Chief Commercial Officer

KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity...


Dec 09, 2014, 08:02 ET KemPharm, Inc. Completes Pre-IND Meeting with FDA for NME Prodrug of Hydromorphone, KP511

 KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity...


Dec 05, 2014, 08:10 ET KemPharm, Inc. Receives Notice of Allowance for NME Prodrug of Methylphenidate, KP415

 KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity...


Sep 30, 2014, 08:10 ET KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511

 KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity...


Sep 23, 2014, 08:10 ET KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada

 KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity...


Sep 08, 2014, 08:10 ET KemPharm, Inc. Advances KP201 Clinical Program with Initiation of Human Abuse Liability and Human Gastrointestinal Motility Trials

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Aug 06, 2014, 11:33 ET KemPharm, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Jun 03, 2014, 08:10 ET KemPharm, Inc. Secures $60 Million Commitment from Deerfield

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Apr 30, 2014, 09:40 ET KemPharm, Inc. Receives Notice of Allowance for Novel Prodrug of Hydromorphone

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Mar 04, 2014, 08:33 ET KemPharm, Inc. Expands Global Intellectual Property Estate for KP201

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Feb 26, 2014, 08:33 ET KemPharm, Inc. to Present at Cowen and Company 34th Annual Health Care Conference

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Feb 05, 2014, 08:33 ET KemPharm, Inc. to Present at 16th Annual BIO CEO & Investor Conference

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Jan 13, 2014, 09:39 ET KemPharm Strengthens its Board of Directors as Company Prepares for Multiple Clinical and Business Milestones in 2014

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Jan 09, 2014, 10:03 ET KemPharm, Inc. to Present at Biotech Showcase™ 2014

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Dec 04, 2013, 14:53 ET KemPharm, Inc. to Present at Oppenheimer 24th Annual Healthcare Conference in New York City

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Nov 01, 2013, 08:33 ET KemPharm Completes Successful End-of-Phase 2 Meeting with FDA

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Oct 23, 2013, 08:10 ET KemPharm Forms Physician Advisory Council Advocating "Intelligent Pain Therapeutic Development"

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Sep 25, 2013, 08:33 ET KemPharm's KP201 Demonstrates Bioequivalence Compared to Norco® in Key Pivotal Clinical Study

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Sep 04, 2013, 08:33 ET KemPharm Continues to Expand its Pain Therapy Pipeline with Discovery of KP606, a Novel Prodrug of Oxycodone

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Aug 28, 2013, 08:33 ET KemPharm's KP201 to be Featured at PAINWeek 2013

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Aug 26, 2013, 08:33 ET KemPharm's KP201 Demonstrates Complete Metabolic Cleavage of Prodrug and Steady-State Pharmacokinetic Profiles for Hydrocodone, Hydromorphone and Acetaminophen

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Aug 07, 2013, 08:10 ET KemPharm, Inc. Receives Additional Notice of Allowance for Novel Prodrugs of Hydrocodone

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Jul 15, 2013, 08:10 ET KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer

 KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...


Jun 11, 2013, 08:33 ET KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201

KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain,...